Autoimmune-associated epilepsy
Seizures driven by the immune system attacking the brain — where recognising the cause early can change treatment from antiseizure medicines to immunotherapy.
In autoimmune-associated epilepsy, seizures are caused by the immune system mistakenly attacking the brain, often as part of autoimmune encephalitis. It is increasingly recognised, including in children. What makes it so important to identify is that, unlike most epilepsies, the seizures may respond poorly to antiseizure medicines but well to immunotherapy — so early recognition can genuinely change the course.
At a glance
- What it is
- Seizures from immune-mediated brain inflammation
- Common antibodies
- Anti-NMDAR, LGI1, CASPR2, GABA-B, GAD65
- Clues
- New, frequent seizures with cognitive, behavioural or psychiatric change
- Key tests
- Antibody testing (serum + CSF), MRI, EEG
- Treatment
- Immunotherapy, often more than antiseizure medicines alone
What it is and how to recognise it
Autoimmune-associated epilepsy occurs when antibodies or immune cells target proteins in the brain, producing seizures that are often frequent and resistant to standard medicines. It frequently appears as part of autoimmune encephalitis, with seizures alongside relatively rapid changes in memory, behaviour, mood, movement or alertness.
Features that raise suspicion include new-onset, frequent or treatment-resistant seizures, a sub-acute onset over days to weeks, faciobrachial dystonic seizures (with LGI1 antibodies), or a background of other autoimmune conditions.
Diagnosis
Assessment combines antibody testing in both blood and spinal fluid, brain MRI, EEG, and tests to exclude infection and other causes; in some antibody types a search for an associated tumour is needed. Because results take time and treatment is time-sensitive, immunotherapy is sometimes started on strong clinical suspicion before all results are back.
Treatment
The mainstay is immunotherapy — typically corticosteroids, intravenous immunoglobulin (IVIG) or plasma exchange first, with medicines such as rituximab or cyclophosphamide if needed. Antiseizure medicines are used alongside, but on their own they are often insufficient. When treated early, many people improve substantially; delay is associated with worse outcomes, which is why prompt recognition matters.
How an educational review can help
An educational review can help make sense of antibody results, MRI and EEG findings, explain how immunotherapy and antiseizure treatment fit together, and help you frame questions for your treating neurologist or immunologist. It is educational and does not replace your clinician's care.
Selected sources
- International consensus and reviews on autoimmune encephalitis and autoimmune-associated epilepsy (incl. paediatric guidance).
- ILAE position on the classification and terminology of autoimmune-associated epilepsy.
Last reviewed: 2026-05-22
Related treatments
Have a report you want explained?
Share your child's records and our specialists will prepare a written educational review.
Start a ReviewZatay Medical provides independent educational reviews only. Our reports are not a diagnosis, treatment, or prescription, and do not replace care from your treating physician.